ImmunoForge is expanding and diversifying its clinical and non-clinical pipeline, focusing on novel drug candidates for rare musculoskeletal diseases.
Millions of patients are suffering from thousands of rare diseases and hundreds of new intractable disorders are diagnosed every year around the world. We can challenge the development of rare disease treatments with cutting-edge technology and a sense of mission and passion. Our motivation is to meet the unmet needs in patients with rare diseases with more tolerable and effective long-term treatment.
We aim to develop first-in-class global drugs with a high probability of success through detailed action plans in candidate selection, preclinical and clinical development, and product approval.
Cutting-edge science and technology are our raw materials, and experience and passion are our tools. We believe that our endeavours will provide a lifeline to those with potentially fatal diseases and enhance the quality of life for those living with chronic conditions. We would like to express our gratitude to all those who care and support us. Your support makes us more passionate. For a better world, we will work harder.